Profit From The Strong Aussie Dollar

When chasing dividend yields, it might pay to look further afield from the obvious choices.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Even after the recent rally, the S&P/ASX 200 index is still down 7% from its April 2011 highs. We've had the possibility of the U.S. losing its sacred triple-A credit rating, the European debt crisis, and a series of poor economic data points at home and abroad, just to name a few of the market's worries.

This pullback does make some stocks appear compelling from a dividend yield viewpoint. The major banks, National Australia Bank (ASX: NAB), Commonwealth Bank (ASX: CBA), Westpac (ASX: WBC) and ANZ (ASX: ANZ) are now all yielding around 6%. Take into account the fully franked nature of their dividends and they have even more attractive yields.

But investors shouldn't just chase yield for the sake of it. The banks have some question marks over them. The cooling housing market and sluggish to falling credit growth raises some concerns about their ability to fund future dividends. That said, people with an investing horizon that can be counted in years rather than days, may see through the short-term economic woes and see today's dividend yields as being tempting.

Yield on Cost

While the banks are yielding quite well right now, they may not have the future growth prospects of other companies. You may be better searching for companies with good dividend growth rates that will hopefully become high yield shares over time, based on your initial cost.

Austin Engineering (ASX: ANG) and Ansell (ASX: ANN) are two that might fit the bill. Austin has a 3 year dividend growth rate of over 30% while Ansell's 8% growth rate is nothing to sneeze at. Who would decline an 8% pay rise?

Neither company is trading on a particularly high dividend yield today, but the goal here is to have your yield-on-cost rise each year as the dividends grow, creating some high yielding shares in your portfolio over time.

Diversification from the Australian Dollar

Getting dividends from Aussie shares is a nice little earner. However, with the Australian dollar riding high compared to its historical norms, this could provide an excellent opportunity to acquire some international blue chips.

There is no denying though that an opportunity to acquire global titans like Johnson & Johnson, 3M and IBM is one worth considering.

3M was trading around $US120 in early June 2001 with the AUD/USD rate around 50c, so the total cost in local currency was $A240 per 3M share. Fast forward to now and 3M is trading around $US95 and the AUD/USD rate is $1.07, so the local currency cost per 3M share is just $A89 per 3M share. Needless to say that is a big difference from the $A240 cost of a decade ago.

Pay cheque from abroad anybody?

The aforementioned blue chips also pay regular dividends. If the strong Aussies dollar loses steam then you'll see a juicer dividend cheque come through the door. A fall in the forex rate may also lead to a possible or even amplified capital gain when you decide to sell these international shares.

This strategy does force you to take a view on the forex rate and adds currency risk to your portfolio. The diversification benefits, however, shouldn't be overlooked. Having U.S. or any international shares adds currency, geographical and sector diversification to your portfolio. This diversification is especially valuable given the resource and material sector dominance of the Aussie share market.

The current opportunity to acquire international blue chip stocks at these favourable exchange rates is worth considering and with the financial year just ended, perhaps it's adding a New (Financial) Year's Resolution to your list?

Fool contributor Mark Tobin does not own any of the shares mentioned in the above article. Mark works for Wilson Asset Management, and that firm or its clients may own any of the shares mentioned above. These positions can change at any time. The Motley Fool has a fine disclosure policy.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »